Phylogix
Waltham
About Phylogix
Phylogix Inc. is a biotechnology company focused on tissue protection and oncology. The company develops lectin-based drugs focused on tissue protection, oncology, and immunology. It also involves in the development of FRIL, an agent to protect patients from the toxic side-effects of chemotherapy. Phylogix Inc. is based in Scarborough, Maine.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $15.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2004)
- Website: phylogix.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Oncology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/phylogix-3069401 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.